TY  - GEN
AU  - Gisslinger,Heinz
AU  - Kees,Mathias
TI  - Therapy strategies for multiple myeloma: current status
SN  - 0043-5325
PY  - 2003///1205
KW  - Adjuvants, Immunologic
KW  - therapeutic use
KW  - Aged
KW  - Angiogenesis Inhibitors
KW  - administration & dosage
KW  - Anti-Inflammatory Agents
KW  - Antineoplastic Agents
KW  - Arsenic Trioxide
KW  - Arsenicals
KW  - Bone Marrow Transplantation
KW  - Boronic Acids
KW  - Bortezomib
KW  - Clinical Trials as Topic
KW  - Clinical Trials, Phase II as Topic
KW  - Dexamethasone
KW  - Diphosphonates
KW  - Drug Therapy, Combination
KW  - Erythropoietin
KW  - Glucocorticoids
KW  - Growth Inhibitors
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Middle Aged
KW  - Multiple Myeloma
KW  - drug therapy
KW  - Oxides
KW  - Peripheral Blood Stem Cell Transplantation
KW  - Protease Inhibitors
KW  - Pyrazines
KW  - Randomized Controlled Trials as Topic
KW  - Stem Cell Transplantation
KW  - Thalidomide
KW  - Time Factors
KW  - Transplantation, Autologous
KW  - Transplantation, Homologous
N1  - Publication Type: Comparative Study; Journal Article; Review
UR  - https://doi.org/10.1007/BF03041028
ER  -